# Predicting age of respiratory syncytial virus infection from birth timing

**Authors:** Chris G. McKennan, Tebeb Gebretsadik, Steven M. Brunwasser, Michael Nodzenski, Daniel J. Jackson, James E. Gern, Pingsheng Wu, Tina V. Hartert

PMC · DOI: 10.1038/s41467-025-67947-3 · 2026-01-13

## TL;DR

A model predicts when infants first get RSV based on birth date and public health data, helping identify those at higher risk for asthma.

## Contribution

A novel interpretable model predicts RSV infection age using birth timing and surveillance data without active monitoring.

## Key findings

- The model explains 37% of the variance in age at first RSV infection.
- It generalizes across four independent U.S. datasets and accurately predicts infection age in two cohorts.
- The model avoids the need for costly active surveillance to estimate RSV infection age.

## Abstract

Respiratory syncytial virus (RSV) infects nearly all children by age 2 to 3 years, and early-life infection—defined using active and passive surveillance with quantitative polymerase chain reaction- and serology-identified infection—has been implicated as a causal factor in childhood asthma. As such, identifying infants that are likely to be infected with RSV during this critical susceptibility window has important implications for identifying individuals at risk for chronic respiratory sequelae. However, determining the age of RSV infection in large populations is challenging because many infections are asymptomatic, making accurate detection dependent on intensive and costly surveillance. To address this, we developed a probability model for age of first RSV infection. It uses an infant’s birthdate, demographic covariates, and publicly available RSV circulation data to determine the probability they were first infected at any age from birth to one year. Our model is interpretable, accounts for nearly 37% of the variance in age at first infection, and generalizes across four independent datasets collected from participants in the United States, where we use it to accurately predict age of first infection in two independent cohorts. Our work facilitates reliable estimation of the age of infant RSV infection during the first year of life without the need for active surveillance.

Early life RSV infection contributes to risk of childhood asthma. Here, the authors develop a statistical model to predict age at first RSV infection in the United States based on birthdate, demographics, and RSV surveillance data which could be used to identify groups at risk of chronic respiratory sequalae like asthma.

## Linked entities

- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** allergy (MESH:D004342), Bronchiolitis (MESH:D001988), Pulmonary Infections (MESH:D012141), Morbidity (OMIM:614963), RSV (MESH:D018357), respiratory disease (MESH:D012140), respiratory sequalae (MESH:D012131), Asthma (MESH:D001249), long-term (MESH:D000088562), Infection (MESH:D007239)
- **Chemicals:** Nirsevimab (MESH:C000709769)
- **Species:** Homo sapiens (human, species) [taxon 9606], Respiratory syncytial virus (no rank) [taxon 12814]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12858871/full.md

---
Source: https://tomesphere.com/paper/PMC12858871